-
Published30/04/2025
-
Deadline02/06/2025
-
Opening of tenders02/06/2025
-
Awarded27/06/2025
-
Today08/08/2026
Utilities
- indicates text translated automatically in your browsing language
Supplies of medicines – Active substance certolizumab pegol – ATC L04AB05
The subject of the contract is the continuous supply of a medicinal product containing the active substance certolizumab pegol – ATC L04AB05. LL- certolizumab pegol, dosage form 200MG INJ SOL ISP 2X1ML, unit of measurement 2X1ML, LL- certolizumab pegol, dosage form 200MG INJ SOL PEP 2X1ML, unit of measurement 2X1ML, quantity 2000
https://www.egordion.cz/nabidkaGORDION/profilTN
https://www.egordion.cz/nabidkaGORDION/profilTN
Postal address:
Town: Praha - Malešice
Postal code: 10800
Country:
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.